Powered by

MediWound Strengthens Board of Directors

Apr 27, 2020 - Nasdaq
Board and Executive Moves

Company Announces Appointments of Samuel Moed and David Fox Chairman Stephen T. Wills Named Executive Chairman YAVNE, Israel , April 27, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced the appointments of Mr. Samuel Moed and Mr. David Fox to its Board of Directors to serve until the 2020 annual meeting of shareholders. Stephen T. Wills ,...